Crossmark

Development and characterization of a novel monoclonal antibody that recognizes an epitope in the central protein interaction domain of RapGEF1 (C3G)

Crossref DOI link: https://doi.org/10.1007/s11033-018-4327-0

Published Online: 2018-08-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Begum, Zareena https://orcid.org/0000-0002-2598-1082
Varalakshmi, Ch. https://orcid.org/0000-0003-0901-0785
Sriram, Divya https://orcid.org/0000-0002-8595-3059
Radha, Vegesna https://orcid.org/0000-0002-1381-2206
Funding

Funding for this research was provided by:

Department of Biotechnology, Govt. of India (BT/PR11759/BRB/10/1301/2014)

Council of Scientific and Industrial Research (BSC0111)
License Information

Text and Data Mining valid from 2018-08-24
More Information

Article History

Received: 27 June 2018

Accepted: 21 August 2018

First Online: 24 August 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Institutional Animal Ethics Committee clearance was obtained for use of animals in the study (IAEC no. 45/2013). All animal experiments and procedures were performed in accordance with the relevant guidelines and regulations on ethical standards for investigation of animals framed by The Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Govt. of India.